Outdoor thermal comfort models are generally developed for healthy populations and may not be directly applicable to patients with altered thermoregulatory capacity. This study examined summer outdoor thermal responses of lung cancer patients in Shenyang, China, focusing on differences by treatment modality and disease stage. Field microclimatic measurements and questionnaire surveys were conducted in four typical outdoor microenvironments: waterfront place, tree-shaded space, open square, and enclosed porch. A total of 706 lung cancer patients were surveyed and stratified by treatment modality and disease stage. Physiologically equivalent temperature (PET) was calculated using RayMan Pro based on measured air temperature, mean radiant temperature, air velocity, relative humidity, clothing insulation, and activity-based metabolic rate. Subgroup differences were observed in neutral PET and thermal comfort ranges. Chemotherapy patients had the highest neutral PET at 26.0 °C, while immunotherapy patients had the lowest at 22.6 °C. Radiotherapy, surgery, and targeted therapy groups showed neutral PET values of 23.3 °C, 23.7 °C, and 24.5 °C, respectively. Early-stage patients had a neutral PET of 23.8 °C, whereas late-stage patients showed a higher value of 25.8 °C and a narrower neutral range of 23.1–28.5 °C. The surgery group had a broad acceptable PET range of 20.5–28.6 °C, while the late-stage group had a narrower range of 24.7–26.8 °C. Preferred temperature was also higher in the chemotherapy and late-stage groups. These findings indicate heterogeneous summer outdoor thermal responses among lung cancer patients and provide empirical evidence for subgroup-sensitive thermal assessment and outdoor space design near healthcare facilities.
Qin et al. (Mon,) studied this question.